title: Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
abstract: Organizations are trying to address the high cost of "specialty" medications that treat conditions such as cancer, hepatitis C, and multiple sclerosis. While comprising less than 1% of U.S. prescriptions, these drugs now account for 27% of pharmacy spending.
authors.forename: Stephen
authors.initials: S
authors.lastname: Barlas